Increased intravitreal adenosine 5′-triphosphate, adenosine 5′-diphosphate and adenosine 5′-monophosphate levels in patients with proliferative diabetic retinopathy

Acta Ophthalmologica

Volumn 93, Issue 1, 2015, Pages 67-73

  Loukovaara, Sirpa ^a   Sahanne, Sari ^a   Jalkanen, Sirpa ^b,c   Yegutkin, Gennady G ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

adenine nucleotides and nucleosides; adenosine 5 triphosphate; diabetic retinopathy; inflammation; purinergic signalling

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOPOIETIN 1; ANGPT1 PROTEIN, HUMAN;

ADULT; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ASSAY; EPIRETINAL MEMBRANE; FLUOROMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PATHOGENESIS; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA MACULA HOLE; SIGNAL TRANSDUCTION; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUMINESCENCE; METABOLISM; MIDDLE AGED; RETINA TEAR;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOPOIETIN-1; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; HUMANS; LUMINESCENT MEASUREMENTS; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL DETACHMENT; RETINAL PERFORATIONS; VITRECTOMY; VITREOUS BODY;

EID: 84921538360     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12507     Document Type: Article

References (45)

1. Aiello LP, Avery RL, Arrigg PG, et al. (1994): Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487.
2. Antonioli L, Blandizzi C, Pacher P, &, Haskõ G, (2013): Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13: 842-857.
3. Arulkumaran N, Turner MT, Sixma ML, Singer M, Unwin R, &, Tam FWK, (2013): Purinergic signalling in inflammatory renal disease. Front Physiol 4: 194.
4. Brandle U, Guenther E, Irrle C, &, Wheeler-Schilling TH, (1998): Gene expression of the P2X receptors in the rat retina. Brain Res 59: 269-272.
5. Burnstock G, &, Novak I, (2013): Purinergic signalling and diabetes. Purinergic Signal 9: 307-324.
6. Burnstock G, &, Ralevic V, (2013): Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66: 102-192.
7. Campwala H, &, Fountain SJ, (2013): Constitutive and agonist stimulated ATP secretion in leukocytes. Commun Integr Biol 6: e23631-e23632.
8. Cogan D, Toussaint D, &, Kuwabara T, (1961): Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 166: 366-378.
9. Costa G, Pereira T, Neto AM, Cristovao AJ, Ambrosio AF, &, Santos PF, (2009): High glucose changes extracellular adenosine triphosphate levels in rat retinal cultures. J Neurosci Res 87: 1375-1380.
10. Crooke A, Guzmán-Aranguez A, Peral A, Abdurrahman MK, &, Pintor J, (2008): Nucleotides in ocular secretions: their role in ocular physiology. Pharmacol Ther 119: 55-73.
11. Elsherbiny NM, Naime M, Ahmad S, et al. (2013a): Potential roles of adenosine deaminase-2 in diabetic retinopathy. Biochem Biophys Res Comm 436: 355-361.
12. Elsherbiny NM, Ahmad S, Naime M, et al. (2013b): ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci 93: 78-88.
13. Eltzschig HK, Sitkowsky MV, &, Robson SC, (2012): Purinergic signaling during inflammation. N Engl J Med 367: 2322-2333.
14. Forrester JV, (2013): Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye 27: 340-352.
15. Fries JE, Wheeler-Schilling TH, Guenther E, &, Kohler K, (2004): Expression of P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes in the rat retina. Invest Ophthalmol Vis Sci 45: 3410-3417.
16. Garweg JG, Tappeiner C, &, Halberstadt M, (2013): Pathophysiology of proliferative vitreoretinopathy in retinal detachment. Surv Ophthalmol 58: 321-329.
17. Ghiardi GJ, Gidday JM, &, Roth S, (1999): The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vision Res 39: 2519-2535.
18. Glen K, Luu NT, Ross E, et al. (2012): Modulation of functional responses of endothelial cells linked to angiogenesis and inflammation by shear stress: differential effects of the mechanotransducer CD31. J Cell Physiol 227: 2710-2721.
19. Gologorsky D, Thanos A, &, Vavvas D, (2012): Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm 2012: 629452.
20. Gombault A, Baron L, &, Couillin I, (2013): ATP release and purinergic signaling in NLPR3 inflammasome activation. Front Immunol 3: 414.
21. Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I, &, Belardinelli L, (2001): Proliferation, migration, and ERK activation in human retinal endothelial cells through A2B adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42: 2068-2073.
22. Greiner JV, Chanes LA, &, Glonek T, (1991): Comparison of phosphate metabolites of the ocular humors. Ophthalmic Res 23: 92-97.
23. Gustavsson C, Agardh CD, &, Agardh E, (2013): Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol 91: 445-452.
24. Guzman-Aranguez A, Santano C, Martin-Gil A, Fonseca B, &, Pintor J, (2013): Nucleotides in the eye: focus on functional aspects and therapeutic perspectives. J Pharmacol Exp Ther 345: 331-341.
25. Helenius M, Jalkanen S, &, Yegutkin GG, (2012): Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochim Biophys Acta 1823: 1967-1975.
26. Howard M, Sen HA, Capoor S, Herfel R, Crooks PA, &, Jacobson MK, (1998): Measurement of adenosine concentration in aqueous and vitreous. Invest Ophthalmol Vis Sci 39: 1942-1946.
27. John GR, Simpson JE, Woodroofe MN, Lee SC, &, Brosnan CF, (2001): Extracellular nucleotides differentially regulate interleukin-1β signaling in primary human astrocytes: implications for inflammatory gene expression. J Neurosci 21: 4134-4142.
28. Kawamura H, Sugiyama T, Wu DM, et al. (2003): ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol 551: 787-799.
29. Kim I, Moon S-O, &, Park SK, (2001): Angiopoietin-1 reduces VEGF-stimulated leucocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin Expression. Circ Res 89: 477-479.
30. Kwak HJ, So JN, Lee SJ, Kim I, &, Koh GY, (1999): Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448: 249-253.
31. Li B, Rosenbaum PS, Jennings NM, Maxwell KM, &, Roth S, (1999): Differing roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Exp Eye Res 68: 9-17.
32. Loukovaara S, Robciuc A, Holopainen JM, et al. (2013): Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy. Acta Ophthalmol 91: 531-539.
33. Loukovaara S, Lehti K, Robciuc A, et al. (2014): Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 252: 881-888.
34. Newman EA, (2003): Glial cell inhibition of neurons by release of ATP. J Neurosci 23: 1659-1666.
35. Noda K, Nakao S, Ishida S, &, Ishibashi T, (2012): Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012: 279037.
36. Notomi S, Hisatomi T, Murakami Y, et al. (2013): Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage. PLoS One 8: e53338.
37. Pintor J, Peral A, Pelaez T, Carracedo G, Bautista A, &, Hoyle CH, (2003a): Nucleotides and dinucleotides in ocular physiology: new possibilities of nucleotides as therapeutic agents in the eye. Drug Dev Res 59: 136-145.
38. Pintor J, Peral A, Peláez T, Martín S, &, Hoyle CH, (2003b): Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J Pharmacol Exp Ther 304: 342-348.
39. Rangasamy S, McGuire PG, &, Das A, (2012): Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol 19: 52-59.
40. Salmi M, &, Jalkanen S, (2012): Ectoenzymes controlling leukocyte traffic. Eur J Immunol 42: 284-292.
41. Sugiyama T, Kobayashi M, Kawamura H, Li Q, &, Puro DG, (2004): Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. Invest Ophthalmol Vis Sci 45: 1026-1032.
42. Thurston G, Rudge J, Ioffe E, et al. (2000): Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
43. Yegutkin GG, (2008): Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673-694.
44. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, &, Caldwell RB, (2012): Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Research 2: 96-103.
45. Zhong Y, Yang Z, Huang WC, &, Luo X, (2013): Adenosine, adenosine receptors and glaucoma: an updated overview. Biochim Biophys Acta 1830: 2882-2890.